A patient with TSC due to a previously unreported deletion of exons 4-8 in TSC2, ASM-resistant epilepsy who responded favorably to phenytoin (PHT) and in whom everolimus led to regression of multifocal epilepsy, to the best of our knowledge, has not been previously reported. This evidence concerns the gene TSC2 and tuberous sclerosis.